Bevacizumab and Recurrent Malignant Gliomas: A European Perspective Reply

被引：5

作者：

Friedman, Henry S. ^{[1
]}

Prados, Michael D. ^{[2
]}

Wen, Patrick Y. ^{[3
,4
]}

Mikkelsen, Tom ^{[5
]}

Schiff, David ^{[6
]}

Abrey, Lauren E. ^{[7
]}

Yung, W. K. Alfred ^{[8
]}

Paleologos, Nina ^{[9
]}

Nicholas, Martin K. ^{[10
]}

Jensen, Randy ^{[11
]}

Vredenburgh, James ^{[12
]}

Huang, Jane ^{[13
]}

Zheng, Maoxia ^{[13
]}

Cloughesy, Timothy ^{[14
]}

机构：

[1] Duke Univ, Preston Robert Tisch Brain Tumor Ctr Duke, Durham, NC 27710 USA

[2] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA

[3] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA

[4] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA

[5] Henry Ford Hosp, Hermelin Brain Tumor Ctr, Detroit, MI 48202 USA

[6] Univ Virginia, Dept Neurol, Charlottesville, VA USA

[7] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA

[8] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA

[9] NorthShore Univ Hlth Syst, Dept Neurol, Evanston, IL USA

[10] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA

[11] Univ Utah Hosp, Salt Lake City, UT USA

[12] Duke Univ, Preston Robert Tisch Brain Tumor Ctr Duke, Durham, NC USA

[13] Genentech Inc, San Francisco, CA 94080 USA

[14] Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 12期

关键词：

CELL LUNG-CANCER; PHASE-III TRIAL; GLIOBLASTOMA-MULTIFORME; PLUS IRINOTECAN; CLINICAL-TRIALS; THERAPY; SURVIVAL; EFFICACY; PATTERNS; CRITERIA;

D O I：

10.1200/JCO.2009.26.9472

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E190 / E192

页数：3

共 23 条

[1]

CHINOT O, 2009, SOC NEUR NEW ORL LA

[2] FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma Multiforme [J].

Cohen, Martin H. ;

Shen, Yuan Li ;

Keegan, Patricia ;

Pazdur, Richard .

ONCOLOGIST, 2009, 14 (11) :1131-1138

[3] Food and Drug Administration drug approval summary: Temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme [J].

Cohen, MH ;

Johnson, JR ;

Pazdur, R .

CLINICAL CANCER RESEARCH, 2005, 11 (19) :6767-6771

[4] Blinded independent central review of progression-free survival in phase III clinical trials: Important design element or unnecessary expense? [J].

Dodd, Lori E. ;

Korn, Edward L. ;

Freidlin, Boris ;

Jaffe, C. Carl ;

Rubinstein, Lawrence V. ;

Dancey, Janet ;

Mooney, Margaret M. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) :3791-3796

[5] Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial [J].

Escudier, Bernard ;

Pluzanska, Anna ;

Koralewski, Piotr ;

Ravaud, Alain ;

Bracarda, Sergio ;

Szczylik, Cezary ;

Chevreau, Christine ;

Filipek, Marek ;

Melichar, Bohuslav ;

Bajetta, Emilio ;

Gorbunova, Vera ;

Bay, Jacques-Olivier ;

Bodrogi, Istvan ;

Jagiello-Gruszfeld, Agnieszka ;

Moore, Nicola .

LANCET, 2007, 370 (9605) :2103-2111

[6]

FINE HA, 2008, J CLIN ONCOL S, V26, pS90

[7] Lessons learned from independent central renew [J].

Ford, R. ;

Schwartz, L. ;

Dancey, J. ;

Dodd, L. E. ;

Eisenhauer, E. A. ;

Gwyther, S. ;

Rubinstein, L. ;

Sargent, D. ;

Shankar, L. ;

Therasse, P. ;

Verweij, J. .

EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :268-274

[8] Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma [J].

Friedman, Henry S. ;

Prados, Michael D. ;

Wen, Patrick Y. ;

Mikkelsen, Tom ;

Schiff, David ;

Abrey, Lauren E. ;

Yung, W. K. Alfred ;

Paleologos, Nina ;

Nicholas, Martin K. ;

Jensen, Randy ;

Vredenburgh, James ;

Huang, Jane ;

Zheng, Maoxia ;

Cloughesy, Timothy .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) :4733-4740

[9] RESPONSE CRITERIA FOR PHASE-II STUDIES OF SUPRATENTORIAL MALIGNANT GLIOMA [J].

MACDONALD, DR ;

CASCINO, TL ;

SCHOLD, SC ;

CAIRNCROSS, JG .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (07) :1277-1280

[10] Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival [J].

Narayana, Ashwatha ;

Kelly, Patrick ;

Golfinos, John ;

Parker, Erik ;

Johnson, Glyn ;

Knopp, Edmond ;

Zagzag, David ;

Fischer, Ingeborg ;

Raza, Shahzad ;

Medabalmi, Praveen ;

Eagan, Patricia ;

Gruber, Michael L. .

JOURNAL OF NEUROSURGERY, 2009, 110 (01) :173-180

← 1 2 3 →